Archive | In the Press

Screen Shot 2016-03-06 at 17.39.07

Wife of CEP co-founder talks to Mail on Sunday about his dependence on prescribed drugs

Julie Montagu, wife of Luke Montagu the co-founder of CEP, is interviewed in the Mail on Sunday today about his horrifying experience withdrawing from an antidepressant and sleeping pill. http://www.dailymail.co.uk/home/you/article-3470982/Julie-Montagu-talks-husband-Luke-s-addiction-prescription-drugs.html

Continue Reading 7

Review of CEP conference ‘More Harm than Good’ in latest Human Givens Journal

The new issue of the Human Givens Journal includes a comprehensive review of CEP’s conference last year entitled ‘More Harm than Good: Confronting the Psychiatric Medication Epidemic’. In addition, the journal contains an article which covers the recent BMA report on prescribed drug dependence, for which CEP contributed evidence. Both articles can be downloaded via […]

Continue Reading 1
Peter Gotzsche

Daily Mail: ‘Psychiatric drugs… third major killer after heart disease and cancer,’ says Prof Peter Gøtzsche

The Daily Mail today publishes two articles describing the devastating and often deadly impact of psychiatric drugs.  In the first piece, Cochrane Collaboration co-founder Prof Peter Gøtzsche details the findings of his new book, Deadly Psychiatry and Organised Denial (2105). “More than 80 million prescriptions for psychiatric drugs are written in the UK every year,” says Gøtzsche. […]

Continue Reading 4
Luke small

Rapid withdrawal and misprescribing of a benzodiazepine leads to £1.35m settlement for Luke Montagu, CEP co-founder

The UK Times Magazine today publishes a long article describing CEP founder Luke Montagu’s terrible experience with antidepressants and sleeping pills: When he was first prescribed these drugs at 19, Montagu was not depressed and had never been diagnosed with depression. He was a student at New York University, and had recently undergone a general […]

Continue Reading 67
Square logo 200x200

Broad press coverage for today’s Maudsley Debate and BMJ article on psychiatric drug harm

Several newspapers have included coverage of today’s Maudsley Debate and BMJ article which consider whether the long-term use of psychiatric drugs is causing more harm than good. The articles include: http://www.theguardian.com/society/2015/may/12/psychiatric-drugs-more-harm-than-good-expert http://www.telegraph.co.uk/news/nhs/11600868/Throw-away-the-antidepressants-urges-leading-scientist.html http://www.independent.ie/life/health-wellbeing/antidepressants-and-drugs-for-dementia-and-adhd-are-harmful-leading-professor-warns-31218279.html Professor Peter Gøtzsche is also mentioned in the lead article on the front page of The Daily Telegraph: http://www.telegraph.co.uk/news/health/news/11601032/NHS-tests-and-drugs-do-more-harm-than-good.html

Continue Reading 4
Peter Gotzsche

BMJ article: is the long-term use of psychiatric drugs harmful?

The BMJ today publishes an article by CEP member Professor Peter Gøtzsche, in which he claims that the long-term use of psychiatric medication is causing more harm than good.  The article is timed to co-incide with a Maudsley Debate which will be held today on the same topic. More than half a million people aged above […]

Continue Reading 15
Screen Shot 2015-05-13 at 08.04.13

The third leading cause of death after heart disease and cancer? Experts debate the harmful effects of psychiatric medications

Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, the Council for Evidence-based Psychiatry (CEP) responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. Taking up this challenge, the Institute of Psychiatry at Kings College London […]

Continue Reading 10
allen-frances

Allen Frances, editor of DSM-IV, developed Risperdal guidelines ‘in disregard of… conflict of interest’

Dr Paula Caplan, associate of the DuBois Research Institute at Harvard University, has written an article exposing historical ties between Dr Allen Frances, lead editor of DSM-IV, and Janssen Pharmaceuticals, a Johnson & Johnson subsidiary and the makers of Risperdal, a second generation antipsychotic. Caplan cites a 2010 court document written by Dr David J Rothman, a […]

Continue Reading 4
logo_lanpsy

Full text of CEP members’ letter to The Lancet Psychiatry in response to article by Nutt et al

David Nutt and colleagues1 represent a brand of psychiatry that wishes to keep its eyes firmly shut when evidence of harms and lack of effectiveness of favoured biological treatments are found. It is therefore unsurprising they take issue with the Council for Evidence-based Psychiatry for publicising evidence that rarely gets discussed; evidence that would enable people […]

Continue Reading 5
logo_lanpsy

CEP members respond to David Nutt and colleagues in letter to The Lancet Psychiatry

The Lancet Psychiatry today published a letter from members of the Council for Evidence-based Psychiatry.  The letter is a response to a previous article in The Lancet Psychiatry entitled “Attacks on antidepressants: signs of deep-seated stigma?” which was contributed by Professor David Nutt, Professor Guy Goodwin and others. CEP’s letter can be seen here (no […]

Continue Reading 0

Powered by WordPress. Designed by WooThemes